Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/21888
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEastwood, Peter R-
dc.contributor.authorBarnes, Maree-
dc.contributor.authorMacKay, Stuart G-
dc.contributor.authorWheatley, John R-
dc.contributor.authorHillman, David R-
dc.contributor.authorNguyên, Xuân-Lan-
dc.contributor.authorLewis, Richard-
dc.contributor.authorCampbell, Matthew C-
dc.contributor.authorPételle, Boris-
dc.contributor.authorWalsh, Jennifer H-
dc.contributor.authorJones, Andrew C-
dc.contributor.authorPalme, Carsten E-
dc.contributor.authorBizon, Alain-
dc.contributor.authorMeslier, Nicole-
dc.contributor.authorBertolus, Chloé-
dc.contributor.authorMaddison, Kathleen J-
dc.contributor.authorLaccourreye, Laurent-
dc.contributor.authorRaux, Guillaume-
dc.contributor.authorDenoncin, Katleen-
dc.contributor.authorAttali, Valérie-
dc.contributor.authorGagnadoux, Frédéric-
dc.contributor.authorLaunois, Sandrine H-
dc.date2019-10-10-
dc.date.accessioned2019-10-14T04:15:37Z-
dc.date.available2019-10-14T04:15:37Z-
dc.date.issued2020-01-09-
dc.identifier.citationThe European respiratory journal 2020 55(1): 1901320-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/21888-
dc.description.abstractHypoglossal Nerve Stimulation (HNS) decreases Obstructive Sleep Apnea (OSA) severity via genioglossus muscle activation and decreased upper airway collapsibility. This study assessed the safety and effectiveness at 6 months post-implantation of a novel device delivering bilateral HNS via a small implanted electrode activated by a unit worn externally, to treat OSA: the Genio™ system. This prospective, open-label, non-randomised, single arm treatment study was conducted at eight centres in three countries (Australia, France, UK). Primary outcomes were incidence of device-related Serious Adverse Events (SAEs) and change in the Apnea-Hypopnea Index (AHI). The secondary outcome was the change in the 4% Oxygen Desaturation Index (ODI). Additional outcomes included measures of sleepiness, quality of life, snoring, and device use. This trial was registered with ClinicalTrials.gov, number NCT03048604. From 27 implanted participants (63% male, aged 55.9±12.0 years, BMI 27.4±3.0 kg·m-2), 22 completed the protocol. At 6 months BMI was unchanged (p=0.85), AHI decreased from 23.7±12.2 to 12.9±10.1 events·hr-1, a mean change of 10.8 events·hr-1 (p<0.001); ODI decreased from 19.1±11.2 to 9.8±6.9 events·hr-1, a mean change of 9.3 events·hr-1 (p<0.001). Daytime sleepiness (ESS, p=0.01) and sleep-related quality of life (FOSQ-10, p=0.02) both significantly improved. The number of bed partners reporting loud, very intense snoring, or leaving the bedroom due to participant snoring decreased from 96% to 35%. Ninety-one percent of participants reported device use >5 days per week, and 77% reported use for >5 hrs per night. No device-related SAE occurred during the 6-months post-implantation period. Bilateral HNS using the Genio™ system reduces OSA severity and improve quality of life without device related complication. The results are comparable with previously published HNS systems despite minimal implanted components and a simple stimulation algorithm.-
dc.language.isoeng-
dc.titleBilateral Hypoglossal Nerve Stimulation for Treatment of Adult Obstructive Sleep Apnea.-
dc.typeJournal Article-
dc.identifier.journaltitleThe European respiratory journal-
dc.identifier.affiliationThe Department of Otolaryngology Head Neck Surgery, Westmead Hospital, Westmead, NSW, Australiaen
dc.identifier.affiliationWest Australian Sleep Disorders Research Institute, Sir Charles Gairdner Hospital, Perth, Western Australia, Australiaen
dc.identifier.affiliationCentre for Sleep Science, School of Human Sciences, University of Western Australia, Perth, Western Australia, Australiaen
dc.identifier.affiliationUniversity of Sydney at Westmead Hospital, Westmead, NSW, Australiaen
dc.identifier.affiliationLudwig Engel Centre for Respiratory Research, The Westmead Institute for Medical Research, Westmead, NSW, Australiaen
dc.identifier.affiliationCentre for Sleep Science, School of Human Sciences, University of Western Australia, Perth, Western Australia, Australiaen
dc.identifier.affiliationWest Australian Sleep Disorders Research Institute, Sir Charles Gairdner Hospital, Perth, Western Australia, Australiaen
dc.identifier.affiliationDept. Otolaryngology, Head & Neck Surgery, Royal Perth Hospital, Perth, Western Australia, Australiaen
dc.identifier.affiliationHollywood Private Hospital, Perth, Western Australia, Australiaen
dc.identifier.affiliationUnité de Somnologie et Fonction Respiratoire, Hopital St Antoine, Paris, Franceen
dc.identifier.affiliationSorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, Franceen
dc.identifier.affiliationDepartment of Respiratory and Sleep Medicine, University Hospital of Angers, Angers, Franceen
dc.identifier.affiliationINSERM UMR 1063 "SOPAM", University of Angers, Angers, Franceen
dc.identifier.affiliationSorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, Franceen
dc.identifier.affiliationAP-HP, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Service des Pathologies du Sommeil (Département "R3S"), Paris, Franceen
dc.identifier.affiliationAP-HP, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Service de Stomatologie et Chirurgie Maxillo-faciale, Paris, Franceen
dc.identifier.affiliationInstitute for Breathing and Sleep, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationUniversity of Melbourne, Parkville, Victoria, Australiaen
dc.identifier.affiliationIllawarra ENT Head & Neck Clinic, Wollongong, NSW, Australiaen
dc.identifier.affiliationWollongong Hospital, Illawarra Shoalhaven Local Health District (ISLHD), Wollongong, NSW, Australiaen
dc.identifier.affiliationGraduate School of Medicine, University of Wollongong, Wollongong, NSW, Australiaen
dc.identifier.affiliationWoolcock Institute of Medical Research, Glebe, NSW, Australiaen
dc.identifier.affiliationDepartment of Respiratory and Sleep Medicine, Westmead Hospital, Westmead, NSW, Australiaen
dc.identifier.affiliationService ORL Chirurgie de la Face et du Cou, Hôpital Tenon, AP-HP, Paris, Sorbonne Université, Paris, France-
dc.identifier.affiliationDept. Otolaryngology, Head &Neck surgery, University Hospital of Angers, France-
dc.identifier.affiliationNyxoah, S.A., Mont-Saint-Guibert, Belgium-
dc.identifier.doi10.1183/13993003.01320-2019-
dc.identifier.orcid0000-0002-4490-4138-
dc.identifier.pubmedid31601716-
dc.type.austinJournal Article-
local.name.researcherBarnes, Maree
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptInstitute for Breathing and Sleep-
crisitem.author.deptEar Nose Throat / Head and Neck Surgery-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

66
checked on Sep 29, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.